Shenzhen Xingchen Visual Culture Co., Ltd. – Trademark Portfolio

Entity Type: 16

Shenzhen Xingchen Visual Culture Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JORVONR. The owner is based in Shenzhen.

101, Building 33, Zone 1, Jianshang New Village, Longtang Community, Minzhi Street, Longhua

Shenzhen 518110 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JORVONR
JORVONR
Registered 2025

Trademark Classifications

Shenzhen Xingchen Visual Culture Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Xingchen Visual Culture Co., Ltd. have?

Shenzhen Xingchen Visual Culture Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Xingchen Visual Culture Co., Ltd. file in?

Shenzhen Xingchen Visual Culture Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Xingchen Visual Culture Co., Ltd.'s most well-known trademarks?

Shenzhen Xingchen Visual Culture Co., Ltd.'s registered trademark portfolio includes well-known marks such as JORVONR. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Xingchen Visual Culture Co., Ltd.'s trademark registration success rate?

Shenzhen Xingchen Visual Culture Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.